Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") is providing...
Day: May 16, 2022
cbdMD Announces Management Changes
Charlotte, North Carolina--(Newsfile Corp. - May 16, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the...
Perimeter Medical Imaging AI to Present at ROTH Canada Showcase Day
TORONTO & DALLAS--(BUSINESS WIRE)--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to...
Premier Geriatric Solutions PLLC Acquires Valley Family and Elder Care to Further Expand in Western Virginia
ROANOKE, VA / ACCESSWIRE / May 16, 2022 / Premier Geriatric Solutions PLLC (PGS), an innovative, rapidly expanding primary and...
Aytu BioPharma Reports Third Quarter 2022 Financial Results and Outlines Key Strategic Priorities
Quarterly Net Revenue Increased 79% Year-Over-Year to $24.2 Million, the Highest Revenue in Company HistoryStrategic Priorities Focused on Driving Revenue...
Celcuity Inc. Reports First Quarter 2022 Financial Results and Business Updates
Entered into $100 Million Private Placement AgreementFinalized pivotal Phase 3 trial design for gedatolisibReceived FDA Fast Track designation for gedatolisib...
Poko Innovations, Inc. Receives Validation and Authorization
TO SELL 44 CBD PRODUCTS IN THE UNITED KINGDOMUK Food Standards Agency (FSA) Validates Poko's ProductsUnder Novel Food ApplicationOnly FSA-Approved...
Planet 13 Announces Q1 2022 Financial Results
Q1 2022 revenue of $25.7 million, up 8% compared to Q1 2021Q1 2022 net loss of $2.1 million, compared to...
Hemostemix Announces Rick Groome as Special Advisor to The CEO
Calgary, Alberta--(Newsfile Corp. - May 16, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company") is...
Britannia Life Sciences to Mobilize Chrysos PhotonAssay(TM) Units in Mining Solutions Division
Britannia Mining Solutions, will install and operate two Chrysos PhotonAssay™ units with the first unit to be delivered in H2...
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - May 16, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or...
CPSI Announces the Creation of the Dream Factory – Fueled by Innovation, Client Input and Elite Talent
MOBILE, Ala.--(BUSINESS WIRE)--$CPSI--CPSI (NASDAQ: CPSI), a healthcare solutions company, welcomes over 800 attendees to its National Client Conference held May...
Raleigh Neurology Associates Partners with athenahealth to Further Its Culture of Excellence in Neurology Care Delivery
One of the nation’s largest independent neurology practices adopts athenaOne® solution to increase staff satisfaction and meet the evolving needs...
iSIGN Reports First Quarter 2022 Results
SAN JOSE, CA / ACCESSWIRE / May 16, 2022 / iSign Solutions Inc. ("iSIGN") (OTC Pink:ISGN), a leading supplier of...
Empower Clinics Provides MCTO Update
VANCOUVER, BC / ACCESSWIRE / May 16, 2022 / Empower Clinics Inc. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (the "Company" or "Empower") is...
iTolerance, Inc. Pre-Clinical Non-Human Primate Study Demonstrates Long-Term Success of Allogeneic Islet Implantation Without Chronic Immunosuppression for the Treatment of Diabetes
Data published in peer-reviewed journal, Science AdvancesCo-implantation of allogeneic islets and streptavidin (SA)-FasL-presenting microgels sustained long-term (>6 months) survival of...
Avinger Announces Key Opinion Leader Presentation and Live Case at Vascular Conferences in Germany
REDWOOD CITY, CA / ACCESSWIRE / May 16, 2022 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the...
FGH to Acquire German Pharmaceutical Distributor
Franchise Global to Acquire German Pharmaceutical and Medical Cannabis Products Distributor, Strengthening its Position in the German Pharmaceutical and Medical...
9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2022
On track to report Phase 2 data for vurolenatide for short bowel syndrome and Phase 3 interim analysis for celiac...
Celcuity Inc. Announces $100 Million Private Placement
Proceeds to Advance Clinical Development of Gedatolisib Including Forthcoming Phase 3 Clinical Study (VIKTORIA-1)MINNEAPOLIS, MN / ACCESSWIRE / May 16,...